Agarose Resin Market Size and Share
| Study Period | 2019 - 2030 |
| Market Size (2025) | USD 0.74 Billion |
| Market Size (2030) | USD 1.13 Billion |
| CAGR (2025 - 2030) | 8.91% |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Agarose Resin Market Analysis by Mordor Intelligence
The Agarose Resin Market size is estimated at USD 0.74 billion in 2025, and is expected to reach USD 1.13 billion by 2030, at a CAGR of 8.91% during the forecast period (2025-2030).
The major factors driving the growth of the agarose resin market include the growing demand for bioprocessing, the increasing importance of chromatography tests, and increasing research and development activities.
The agarose resin is widely adopted by various pharmaceutical and biopharmaceutical companies for drug purification purposes owing to its multiple advantages, thereby driving its demand worldwide. For instance, according to the article published by the Marine Drugs Journal in May 2023, agarose, a polysaccharide derived from marine red algae, plays a vital role in biomedical applications owing to its reversible temperature-sensitive gelling behavior, excellent mechanical properties, and high biological activity. As per the same source, agarose can be transformed into different forms through physical, biological, and chemical modifications and is increasingly used for isolation, purification, drug delivery, and tissue engineering applications. In addition, the rise in investment in the biopharmaceutical field is also expected to drive market growth over the forecast period. Both academic research institutions and pharmaceutical companies invest heavily in biotechnology and bioprocessing research, which drives the demand for agarose resins for purification purposes. For instance, as per the report of Department of Health and Human Services published in September 2022, the United States government planned to invest USD 40 million to expand the role of biomanufacturing for active pharmaceutical ingredients (APIs), antibiotics, and the critical starting materials needed to produce essential medications and respond to pandemics in the United States. Therefore, such investments are projected to drive the demand for agarose resin as it plays a crucial role in the purification of these complex biomolecules, thereby driving demand for agarose-based chromatography media.
In addition, the increasing investment by government organizations to advance the biopharmaceutical and life science sector is expected to favor the market's growth during the forecast period. For instance, in March 2022, the United Kingdom government invested up to EUR 260 million (USD 276.34 million) in the new Life Sciences Innovative Manufacturing Fund (LSIMF) to advance life sciences manufacturing projects in both medical diagnostics and human medicines. Also, in October 2022, the United Kingdom Government funded more than USD 894.6 million to support the research and experimental therapies and to address patient safety challenges in the country. The National Institute for Health and Care Research (NIHR) allocated the funds to expert research facilities across the UK. The increasing government investment in the biopharmaceutical and life science sector, exemplified by the United Kingdom's significant funding allocations through initiatives like the Life Sciences Innovative Manufacturing Fund (LSIMF) and the National Institute for Health and Care Research (NIHR), is expected to drive the demand of the agarose resin market during the forecast period. As the research in life sciences, including genomics, proteomics, and molecular biology, relies heavily on chromatography techniques for biomolecule analysis and purification, it is projected to boost the demand for agarose resin.
Moreover, the active participation of prominent players in increasing the production of agarose resins, with the surge in demand from the biopharmaceutical sector, is also projected to enhance market growth during the forecast period. For instance, in November 2022, Purolite introduced that its Praesto agarose-based Protein A and Ion Exchange chromatography resins were expected to be available in South Korea and Singapore. Purolite offer these products through an enhanced strategic partnership with PharmNXT Biotech, which provides solutions to Pharma and broader Life Sciences markets. Additionally, in August 2022, Agarose Bead Technologies (ABT) announced its plan to increase the production volumes of various agarose beads by expanding an additional 1,000 square meters of production space.
Therefore, factors such as growing demand for bioprocessing and increasing research and development activities are projected to enhance agarose resin market growth during the forecast period. However, high costs and regulatory challenges may restrain the market growth during the forecast period.
Global Agarose Resin Market Trends and Insights
Protein Purification Segment is Expected to Hold a Highest Share of the Market
Agarose resin's high resolution and compatibility with biocompatible conditions make it a valuable tool in achieving protein purity and ensuring the quality of biopharmaceutical and research-grade proteins. The protein purification segment within the agarose resin market serves a wide range of applications, including the production of therapeutic proteins, research in molecular biology and biotechnology, structural biology studies, and the development of diagnostics and vaccines. The critical role of agarose resin in ensuring the quality and purity of biopharmaceutical products further solidifies its position in purification applications.
The growth of the protein purification application segment in the agarose resin market is propelled by the expanding biopharmaceutical industry, increasing demand for therapeutic proteins and vaccines, advancements in bioprocessing, and ongoing research in fields such as gene therapy and regenerative medicine.
The high burden of chronic diseases has boosted the research investments and funding for advancing the research of nucleic acids, genetics, and nucleic acid-based therapeutics and diagnosis for the timely and effective management of the diseases. For instance, as per the data published by the National Center for Health Statistics (NCHS) in March 2023, research investments in nucleic acid-based research are expected to increase in the coming years in the United States. The source stated that the research funding in Genetics will likely elevate from USD 11,615 million in FY 2022 to USD 12,445 million by 2024. The same source reported that the research investments in Genetic Testing are anticipated to increase from USD 214 million in 2022 to USD 237 million by 2024. Also, the research funding in gene therapy will rise from USD 516 million in 2022 to USD 540 million by 2024. This is projected to drive the demand of agarose resin for the separation of large molecules, especially DNA, by electrophoresis, thereby driving the market growth.
Furthermore, the advancements in protein extraction and purification technologies are projected to drive the demand for agarose resin during the forecast period. For instance, in February 2023, BioEcho Life Sciences, a Germany-based biotechnology company, received the patents of EchoLUTION technology for protein extraction and purification from the United States Patent and Trademark Office and the Japan Patent Office. EchoLUTION technology allows DNA and RNA extraction in one single centrifugation step: Nucleic acids pass through the purification matrix having agarose in it, while impurities are held back and ultimately removed. The result is high-quality, inhibitor-free DNA or RNA ready for downstream applications.
Therefore, factors such as the expanding biopharmaceutical industry, increased investments, and rising technological advancements are projected to enhance market growth during the forecast period.
North America is Expected to Hold the Significant Share of the Market Over the Forecast Period
North America is expected to hold a significant share of the agarose resin market over the forecast period owing to the rising investments in the biopharmaceutical sector across the United States, Canada, and Mexico and rising advancements in chromatography technologies.
The rising investment in the biopharmaceutical sector in the region is projected to drive the growth of the agarose resins market during the forecast period. For instance, in September 2022, the United States government invested over USD 2 billion to launch its biomanufacturing initiative, which aims to expand manufacturing capacity in the country and ensure pandemic preparedness. The “Benchmarking Synthetic Biology Product Development” project announced by the government is expected to increase the commercial readiness of bio-products throughout the bioindustrial manufacturing ecosystem. In addition, the government authorities in Canada are highly focused on the biomanufacturing and pharma sectors to meet the rising demand for medicines and biologics. For instance, according to the June 2023 update by the Government of Canada, the Government of Canada invests more than USD 2.1 billion in 36 projects in the biomanufacturing, vaccine, and therapeutics ecosystem, strengthening domestic pandemic response capabilities and life science innovation. The investments are spread across British Columbia, Alberta, Saskatchewan, Quebec, Ontario, and Atlantic Canada. Thus, such investment in biomanufacturing will likely create a high demand for agarose resins in the country, fueling market growth over the forecast period.
Moreover, prominent regional players' rising number of strategic activities such as increasing product launches and acquisitions is also projected to drive market growth during the forecast period. For instance, In July 2022, MicroSolv Technology Corporation, a manufacturer of HPLC columns and other products for Separation Sciences, acquired Applied Research Europe GmbH of Berlin, Germany, a manufacturer of chromatography accessories including agarose resins. The acquisition likely broadens MicroSolv's product portfolio, incorporating agarose resins and related chromatography accessories. This expansion enables MicroSolv to offer a more comprehensive range of solutions to its customers in North America.
Therefore, factors such as rising investments in the biopharmaceutical sector across the United States, Canada, and Mexico and advancements in chromatography technologies are projected to accelerate market growth during the forecast period.
Competitive Landscape
The Agarose Resin market is semi consolidated in nature. Prominent players are participating in new product launches, acquisitions, and collaborations to uphold their position in the market. Some of the key players in the studied market include Ecolab Inc. (Purolite), Takara Bio Inc., Bio-Rad Laboratories, Inc., and Cube Biotech Inc., among others.
Agarose Resin Industry Leaders
-
Ecolab Inc. (Purolite)
-
Takara Bio Inc.
-
Bio-Rad Laboratories, Inc.
-
Cube Biotech Inc.
-
Cytiva
- *Disclaimer: Major Players sorted in no particular order
Recent Industry Developments
- In April 2024, Agarose Beads Technologies received halal certification for some of its agarose beads used in the biopharmaceutical and bioprocessing industries, ensuring a strong commitment to high quality and customer satisfaction.
- In February 2024, Purolite and Repligen Corporation introduced a new 70-micrometer agarose-based affinity resin, Praesto CH1, developed to purify monoclonal antibodies, including bispecifics and recombinant antibody fragments.
Global Agarose Resin Market Report Scope
As per the report's scope, agarose resin is a specialized type of chromatography resin used to purify and separate biomolecules, particularly in biopharmaceutical and life sciences applications. It is derived from agarose, a natural polysaccharide extracted from seaweed. The Agarose Resin Market is segmented by concentration, application, end user and geography. By concentration, the market is segmented into 2% to 4%, 4% to 6%, 6% to 8%, and more than 8%. By application, the market is segmented into protein purification, antibody purification, immunoprecipitation, and others. By end user, the market is segmented into pharmaceutical and biopharmaceutical companies, research laboratories, and other end users. By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. For each segment, the market size is provided in terms of USD value.
| 2% to 4% |
| 4% to 6% |
| 6% to 8% |
| More than 8% |
| Protein Purification |
| Antibody Purification |
| Immunoprecipitation |
| Others |
| Pharmaceutical and Biopharmaceutical Companies |
| Research Laboratories |
| Other End Users |
| North America | United States |
| Canada | |
| Mexico | |
| Europe | Germany |
| United Kingdom | |
| France | |
| Italy | |
| Spain | |
| Rest of Europe | |
| Asia-Pacific | China |
| Japan | |
| India | |
| Australia | |
| South Korea | |
| Rest of Asia-Pacific | |
| Middle East and Africa | GCC |
| South Africa | |
| Rest of Middle East and Africa | |
| South America | Brazil |
| Argentina | |
| Rest of South America |
| By Concentration | 2% to 4% | |
| 4% to 6% | ||
| 6% to 8% | ||
| More than 8% | ||
| By Application | Protein Purification | |
| Antibody Purification | ||
| Immunoprecipitation | ||
| Others | ||
| By End User | Pharmaceutical and Biopharmaceutical Companies | |
| Research Laboratories | ||
| Other End Users | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Europe | Germany | |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Asia-Pacific | China | |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Middle East and Africa | GCC | |
| South Africa | ||
| Rest of Middle East and Africa | ||
| South America | Brazil | |
| Argentina | ||
| Rest of South America | ||
Key Questions Answered in the Report
How big is the Agarose Resin Market?
The Agarose Resin Market size is expected to reach USD 0.74 billion in 2025 and grow at a CAGR of 8.91% to reach USD 1.13 billion by 2030.
What is the current Agarose Resin Market size?
In 2025, the Agarose Resin Market size is expected to reach USD 0.74 billion.
Who are the key players in Agarose Resin Market?
Ecolab Inc. (Purolite), Takara Bio Inc., Bio-Rad Laboratories, Inc., Cube Biotech Inc. and Cytiva are the major companies operating in the Agarose Resin Market.
Which is the fastest growing region in Agarose Resin Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Agarose Resin Market?
In 2025, the North America accounts for the largest market share in Agarose Resin Market.
What years does this Agarose Resin Market cover, and what was the market size in 2024?
In 2024, the Agarose Resin Market size was estimated at USD 0.67 billion. The report covers the Agarose Resin Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Agarose Resin Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Page last updated on:
Agarose Resin Market Report
Statistics for the 2025 Agarose Resin market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Agarose Resin analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
